bay x 1005 has been researched along with Pleurisy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahr, HJ; Beckermann, B; Bühner, K; Fruchtmann, R; Kohlsdorfer, C; Mohrs, KH; Müller-Peddinghaus, R; Perzborn, E; Theisen-Popp, P | 1 |
1 other study(ies) available for bay x 1005 and Pleurisy
| Article | Year |
|---|---|
BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
Topics: Animals; Biological Assay; Edema; Female; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pleurisy; Protein Binding; Quinolines; Rats | 1993 |